SCHEMBL8434329

SCHEMBL8434329

CCCCc1ncc(COC(C)=O)n1Cc1ccc(OCC(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8434213 0.82 AGTR1 (0.56) AGTR1
SCHEMBL9139865 0.79 AGTR1 (0.48) AGTR1
SCHEMBL6972578 0.77 — —
SCHEMBL812 0.75 AGTR1 (0.60) AGTR1
SCHEMBL8433706 0.73 AGTR1 (0.55) AGTR1
SCHEMBL8434336 0.73 AGTR1 (0.58) AGTR1
SCHEMBL12611895 0.72 ALDH1A1 (0.61) —
SCHEMBL8333499 0.72 ALDH1A1 (0.59) —
SCHEMBL7268388 0.71 AGTR1 (0.36) AGTR1
SCHEMBL5547472 0.71 AGTR1 (0.72) AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929249-A ANGIOTENSIN II RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-07-27 — — US disclosed
US-5728842-A ANGIOTENSIN II RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORPORATION (US) 1998-03-17 — — US disclosed
EP-0653937-A4 CHEMICAL COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1996-07-31 — — EP disclosed
EP-0653937-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-05-24 — — EP disclosed
WO-1994000120-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-01-06 — — WO disclosed
WO-1993006828-A1 MEDICAMENT FOR THE TREATMENT OF ANXIETY SMITHKLINE BEECHAM CORPORATION (US) 1993-04-15 — — WO disclosed
Send feedback